← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Amydis Diagnostics, Inc.
La Jolla, CA
$16,496,188
Total funding
11
Grants
Funding over time
peak $4.2M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,496,188 · 11
By mechanism
R44$7,765,167 · 4
SB1$6,453,722 · 2
R43$2,277,299 · 5
Investigators at Amydis Diagnostics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics$2,077,573
R44 · FY2021 · NS
Use of novel fluorescent tracers to develop a comprehensive retinal biomarker database that maps the heterogeneity of Alzheimer's pathogenesis$1,715,680
SB1 · FY2024 · AG
Use of novel fluorescent tracers to develop a comprehensive retinal biomarker database that maps the heterogeneity of Alzheimer's pathogenesis$1,704,372
SB1 · FY2023 · AG
Development of an ophthalmic diagnostic probe for neurodegenerativedisorders$1,647,908
R44 · FY2016 · AG
Development of an ophthalmic diagnostic probe for cerebral amyloid angiopathy in patients$1,590,883
SB1 · FY2021 · AG
Development of an ophthalmic diagnostic probe for cerebral amyloid angiopathy in patients$1,442,787
SB1 · FY2022 · AG
Development of a topical tracer to detect TDP43 in ALS, LATE and FTD retinas for AI-powered disease insights$1,388,697
R44 · FY2025 · AG
Development of a novel ophthalmic probe for cerebral amyloid angiopathy$1,049,456
R44 · FY2020 · AG
Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics$900,109
R44 · FY2022 · NS
Development of a Novel Diagnostic Probe for Cerebral Amyloid Angiopathy$534,525
R43 · FY2017 · AG
Development of Novel Tau Retinal Tracers for Alzheimer's Disease and other Tauopathies$492,212
R43 · FY2021 · AG
Development of a novel ophthalmic probe for cerebral amyloid angiopathy$490,250
R44 · FY2019 · AG
Development of a novel fluorescent tracer for detection of retinal TDP43 in ALS and FTD$458,527
R43 · FY2022 · AG
Development of Novel Prion Disease Diagnostic$408,225
R43 · FY2018 · AG
Development of an ophthalmic diagnostic probe for neurodegenerative disorders$383,810
R43 · FY2015 · AG
Development of an ophthalmic diagnostic probe for neurodegenerativedisorders$211,174
R44 · FY2017 · AG